{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:54:32Z","timestamp":1782168872699,"version":"3.54.5"},"reference-count":48,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Compared with oral or injection administration, percutaneous immunotherapy presents a promising treatment modality for food allergies, providing low invasiveness and safety. This study investigated the efficacy of percutaneous immunotherapy using hen egg lysozyme (HEL)-loaded PLGA-PEG-PLGA nanoparticles (NPs), as an antigen model protein derived from egg white, compared with that of HEL-loaded chitosan hydroxypropyltrimonium chloride (CS)-modified PLGA NPs used in previous research. The intradermal retention of HEL in excised mouse skin was measured using Franz cells, which revealed a 2.1-fold higher retention with PLGA-PEG-PLGA NPs than that with CS-modified PLGA NPs. Observation of skin penetration pathways using fluorescein-4-isothiocyanate (FITC)-labeled HEL demonstrated successful delivery of HEL deep into the hair follicles with PLGA-PEG-PLGA NPs. These findings suggest that after NPs delivery into the skin, PEG prevents protein adhesion and NPs aggregation, facilitating stable delivery deep into the skin. Subsequently, in vivo percutaneous administration experiments in mice, with concurrent iontophoresis, demonstrated a significant increase in serum IgG1 antibody production with PLGA-PEG-PLGA NPs compared with that with CS-PLGA NPs after eight weeks of administration. Furthermore, serum IgE production in each NP administration group significantly decreased compared with that by subcutaneous administration of HEL solution. These results suggest that the combination of PLGA-PEG-PLGA NPs and iontophoresis is an effective percutaneous immunotherapy for food allergies.<\/jats:p>","DOI":"10.3390\/molecules29174123","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T09:39:32Z","timestamp":1725010772000},"page":"4123","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Application of PLGA-PEG-PLGA Nanoparticles to Percutaneous Immunotherapy for Food Allergy"],"prefix":"10.3390","volume":"29","author":[{"given":"Ryuse","family":"Sakurai","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Iwata","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Modality Research Group, BioPharma Research Institute, Kaneka Corporation Inc., 1\u22128 Miyamae-cho, Takasago-cho, Takasago-shi 676\u22128688, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[{"name":"Modality Research Group, BioPharma Research Institute, Kaneka Corporation Inc., 1\u22128 Miyamae-cho, Takasago-cho, Takasago-shi 676\u22128688, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0611-7387","authenticated-orcid":false,"given":"Issei","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"},{"name":"Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo, Togane 283\u22128555, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Makino","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Itoh","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"},{"name":"Department of Gastroenterology, St. Marianna University School of Medicine, 2\u221216\u22121 Sugao, Miyamae-ku 216\u22128511, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641, Yamazaki, Noda 278\u22128510, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Loh, W., and Tang, M.L.K. (2018). The epidemiology of food allergy in the global context. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15092043"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0140-6736(13)60309-8","article-title":"IgE-mediated food allergy in children","volume":"382","author":"Longo","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ACI.0000000000000271","article-title":"Food allergy quality of life and living with food allergy","volume":"16","author":"Greenhawt","year":"2016","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cea.13548","article-title":"Anxiety and food allergy: A review of the last two decades","volume":"50","author":"Polloni","year":"2020","journal-title":"Clin. Exp. Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5414\/ALX02319E","article-title":"Allergen immunotherapy for food allergy: Evidence and outlook","volume":"6","author":"Muraro","year":"2022","journal-title":"Allergol. Sel."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2222.2009.03430.x","article-title":"Benhamou. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy","volume":"40","author":"Mondoulet","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s40521-013-0003-8","article-title":"K\u00fcndig. Epicutaneous immunotherapy for aeroallergen and food allergy","volume":"1","author":"Senti","year":"2014","journal-title":"Curr. Treat. Options Allergy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.21817","article-title":"Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality?","volume":"99","author":"Baroli","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: A review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/21691401.2018.1430695","article-title":"Passive delivery of protein drugs through percutaneous route","volume":"46","author":"Chaulagain","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jaci.2016.01.008","article-title":"Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch","volume":"137","author":"Jones","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11095-019-2728-y","article-title":"Immunogenicity of milk protein-containing hydrophilic gel patch for epicutaneous immunotherapy for milk allergy","volume":"37","author":"Ito","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jconrel.2013.08.018","article-title":"Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using optical coherence tomography and two-photon microscopy","volume":"172","author":"Rattanapak","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2012.06.031","article-title":"Transcutaneous vaccination via laser microporation","volume":"162","author":"Weiss","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1517\/17425247.2013.773970","article-title":"Laser microporation of the skin: Prospects for painless application of protective and therapeutic vaccines","volume":"10","author":"Scheiblhofer","year":"2013","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejpb.2018.05.031","article-title":"Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery","volume":"129","author":"Pontier","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_22","first-page":"1","article-title":"Influencing factors and drug application of iontophoresis in percutaneous drug delivery: An overview of recent progress","volume":"12","author":"Wang","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40005-019-00453-z","article-title":"Poly (lactic acid)\/poly (lactic-co-glycolic acid)-based microparticles: An overview","volume":"49","author":"Blasi","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112916","DOI":"10.1016\/j.colsurfb.2022.112916","article-title":"Chitosan-coated PLGA nanoparticles for transcutaneous immunization: Skin distribution in lysozyme-sensitized mice","volume":"220","author":"Takeuchi","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"124866","DOI":"10.1016\/j.colsurfa.2020.124866","article-title":"Skin permeability and transdermal delivery route of 30-nm cyclosporin A-loaded nanoparticles using PLGA-PEG-PLGA triblock copolymer","volume":"600","author":"Takeuchi","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Heine, S., Aguilar-Pimentel, A., Russkamp, D., Alessandrini, F., Gailus-Durner, V., Fuchs, H., Ollert, M., Bredehorst, R., Ohnmacht, C., and Zissle, U.M. (2022). Thermosensitive PLGA\u2013PEG\u2013PLGA hydrogel as depot matrix for allergen-specific immunotherapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081527"},{"key":"ref_27","first-page":"67","article-title":"Liposomes Affect Protein Release and Stability of ITA-Modified PLGA-PEG-PLGA Hydrogel Carriers for Controlled Drug Delivery","volume":"25","author":"Sevriugina","year":"2023","journal-title":"Biomacromolecules"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"112040","DOI":"10.1016\/j.eurpolymj.2023.112040","article-title":"Enhanced hydrophilicity of one-step electrosprayed red blood cell-like PLGA microparticles by block polymer PLGA-PEG-PLGA with excellent magnetic-luminescent bifunction and affinity to HUVECs","volume":"191","author":"Xu","year":"2023","journal-title":"Eur. Polym. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.colsurfa.2014.05.010","article-title":"Surfactant free preparation of PLGA nanoparticles: The combination of antisolvent diffusion with preferential solvation","volume":"457","author":"Tomoda","year":"2014","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2012.03.040","article-title":"Penetration and release studies of positively and negatively charged nanoemulsions\u2014Is there a benefit of the positive charge?","volume":"430","author":"Baspinar","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2008.11.014","article-title":"Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation","volume":"370","author":"Hoeller","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.seppur.2011.09.002","article-title":"Analysis of hydrophobic charge induction displacement chromatography by visualization with confocal laser scanning microscopy","volume":"82","author":"Zhao","year":"2011","journal-title":"Sep. Purif. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/bc00013a001","article-title":"A brief survey of methods for preparing protein conjugates with dyes, haptens, and crosslinking reagents","volume":"3","author":"Brinkley","year":"1992","journal-title":"Bioconjugate Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"125607","DOI":"10.1016\/j.colsurfa.2020.125607","article-title":"Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for transcutaneous immunization","volume":"608","author":"Takeuchi","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1679\/aohc.66.123","article-title":"Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants","volume":"66","author":"Kawamoto","year":"2003","journal-title":"Arch. Histol. Cytol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e47980","DOI":"10.1371\/journal.pone.0047980","article-title":"Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response","volume":"7","author":"Tokuyama","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lu, B., Lv, X., and Le, Y. (2019). Chitosan-modified PLGA nanoparticles for control-released drug delivery. Polymers, 11.","DOI":"10.3390\/polym11020304"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.2042-7158.2011.01376.x","article-title":"Cellular delivery of PEGylated PLGA nanoparticles","volume":"64","author":"Pamujula","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Control. Release"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e0251821","DOI":"10.1371\/journal.pone.0251821","article-title":"Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology","volume":"16","author":"Mares","year":"2021","journal-title":"PLoS ONE"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/D1MA00600B","article-title":"Formulation of PLGA nano-carriers: Specialized modification for cancer therapeutic applications","volume":"3","author":"Chatterjee","year":"2022","journal-title":"Mater. Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/anie.201206563","article-title":"A structured monodisperse PEG for the effective suppression of protein aggregation","volume":"52","author":"Muraoka","year":"2013","journal-title":"Angewandte chemie"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2017.03.045","article-title":"Allergen-specific IgG antibody signaling through Fc\u03b3RIIb promotes food tolerance","volume":"141","author":"Burton","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaci.2022.10.003","article-title":"Mast cells in food allergy: Inducing immediate reactions and shaping long-term immunity","volume":"151","author":"Oettgen","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4049\/jimmunol.180.3.1482","article-title":"Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans","volume":"180","author":"Vogt","year":"2008","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e89503","DOI":"10.1371\/journal.pone.0089503","article-title":"Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization","volume":"9","author":"Rattanapak","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(01)00862-6","article-title":"Investigation of the adjuvant effect of polyethylene glycol (PEG) 400 in BALB\/c mice","volume":"231","author":"Larsen","year":"2002","journal-title":"Int. J. Pharm."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/17\/4123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:45:52Z","timestamp":1760111152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/17\/4123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":48,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["molecules29174123"],"URL":"https:\/\/doi.org\/10.3390\/molecules29174123","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}